Blog

Articles, insights, and posts about Child Development, early detection, and new methods in diagnosis and treatment.

Latest articles

• 

  FDNA and Microsoft Collaborate to Enhance Genomics Technology Through AI

  FDNA and Microsoft Genomics are working together to integrate the most advanced Artificial Intelligence solutions to support clinical genomics. Combining next-generation phenotyping (NGP), with next-generation sequencing (NGS) enables today’s health and life science organizations to reach more thorough, accurate, and actionable results and improve healthcare outcomes. Microsoft Genomics and FDNA are empowering stakeholders to use […]

  Continue reading
• 

  FDNA and Face2Gene Featured at ESHG

    A flock of researchers from around the globe shared their findings in dysmorphology and molecular genetics at this year’s ESHG as a part of FDNA’s corporate satellite talk and various scientific posters. Karin Weiss (Rambam Health Care Campus, Haifa, Israel) presented her further work on Sifrim Hitz Weiss Syndrome (SIHIWES), a recently described form […]

  Continue reading
• 

  Redefining Phenotyping for Clinical Advancements and Variant Prioritization

  FDNA’s CEO, Dekel Gelbman, joined two distinguished members of the genetics community—Dr. John Carey (University of Utah) and Dr. Christine Stanley (WuXi NextCODE)—on redefining phenotyping for clinical advancements and variant prioritization. Dr. Carey. a highly-practiced clinician, currently at the University of Utah’s Department of Medical Genetics, kicked off the webinar with a comprehensive background on […]

  Continue reading
• 

  Happening at HIMMS: Precision Medicine Through Next-Generation Phenotyping—A Customer’s Journey

  HIMSS Conference, Microsoft booth Thursday, March 7 3:40 PM PST Las Vegas, Nevada As over 40,000 health IT professionals, clinicians, executives, and vendors from around the world gather at this year’s HIMSS Annual Conference & Exhibition, speaker Anthony Antonuccio, VP of Product at FDNA shares FDNA’s experience with one of the leading clinics, Greenwood Genetic […]

  Continue reading
• 

  FDNA Announces Genomics Collaborative® at a Global Innovation Summit

  English | Spanish In a packed auditorium at Mexico City’s CENTRO University, FDNA’s Senior Director of Marketing, Jeff Daniels, announced the launch of the Genomics Collaborative. This initiative prompts clinicians, patients, advocates and researchers to join forces in an effort to accelerate breakthroughs in precision medicine. The Genomics Collaborative allows participants to access FDNA’s deep […]

  Continue reading
• NIH offering $190 million to research somatic gene editing

  The National Institutes of Health (NIH) recently launched a program to accelerate the transition of genome editing into clinical applications. Over the next six years, this Somatic Cell Genome Editing program aims to award $190 million to researchers for projects focused on creating and improving gene editing tools and delivery systems, testing the efficacy and […]

  Continue reading
• 

  2017 Year in Review

  At FDNA, we’re making precision medicine a reality by crowdsourcing knowledge and integrating next-generation phenotyping (NGP) technologies into every patient evaluation. NGP is the computational capture, analysis and integration of phenotypic data into health analysis—a hallmark of FDNA’s technologies. In 2017, our Face2Gene application turned five, and alongside our collaborators, we marked some serious milestones: […]

  Continue reading
• 

  Drug Delivery Partnership: Precision Medicine Drives Discovery, Development and Commercialization in Pharma

  In an era of breakthrough advancements in healthcare, it is hard to believe that 90% of blockbuster medicines are only effective for 30-50% of patients. The reason? A “one-size-fits-all” approach to pharmaceutical development and commercialization. At this year’s 22nd Annual Drug Delivery Partnership meeting, a new approach to the pharma value chain is in discussion. […]

  Continue reading
• 

  Skin Disorders Discoveries in the Year of Discovery

  December Discoveries – Skin Disorders As part of FDNA’s Year of Discovery, FDNA collaborated with the National Foundation for Ectodermal Dysplasias, sponsored by GeneDx, to research and promote awareness of Skin Disorders throughout the month of December. About Skin Disorders Abnormalities of the hair, skin, sweat glands, nails, and teeth are frequently associated with various […]

  Continue reading